Ingo Stehle

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

C. Schumann, M. Scheffler, D. Heigener, 2015, The oncologist.

What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

Christina Backes, Eckart Meese, Andreas Keller, 2014, Oncotarget.

Busulfan depletes neutrophils and delays accelerated acute rejection of discordant xenografts in the guinea pig-to-rat model

M. Kremer, C. Heidecke, Ingo Stehle, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

Busulfan depletes neutrophils and delays accelerated acute rejection of discordant xenografts in the guinea pig‐to‐rat model

M. Kremer, C. Heidecke, Ingo Stehle, 2003 .

Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma

Eckart Meese, Andreas Keller, Hans-Peter Lenhof, 2008, International journal of cancer.

Novel autoantigens immunogenic in COPD patients

Hans-Peter Lenhof, A. Keller, P. Leidinger, 2009, Respiratory research.

Identification of lung cancer with high sensitivity and specificity by blood testing

Eckart Meese, Andreas Keller, Hans-Peter Lenhof, 2010, Respiratory research.

Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients.

Christina Backes, Benjamin Meder, Eckart Meese, 2020, JAMA oncology.

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

C. Schumann, M. Scheffler, D. Heigener, 2015, The oncologist.

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system

A. Scott, M. Brechbiel, M. Pfreundschuh, 2001, Cancer Immunology, Immunotherapy.